The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans

M. Feldmesser, Y. Kress, A. Mednick, A. Casadevall

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

The echinocandin derivative caspofungin (MK-0991, L-743,872) inhibits 1,3-β-D-glucan synthesis and is active against several medically important fungi but is relatively ineffective against Cryptococcus neoformans. To investigate the mechanism of C. neoformans resistance, the prevalence of 1,3- and 1,6-β-D-glucan linkages was determined in cells grown with and without caspofungin, using affinity-purified antisera and gold particle immunoelectron microscopy. Cryptococcal strains ATCC 24067 (serotype D) and MY2061 (serotype A) were studied. Growth at 4 μg/mL of caspofungin reduced both glucan linkages in both strains. However, growth at 2 μg/mL resulted in reduced 1,6-β-D-glucan linkage only for MY2061. Inhibition of 1,6-β-D-glucan synthesis may be an additional mechanism of action for pneumocandins. The relatively low efficacy of caspofungin against C. neoformans may result from reduced activity against C. neoformans glucan synthase or from yet undiscovered mechanisms of action operative in other fungal pathogens but not in C. neoformans.

Original languageEnglish (US)
Pages (from-to)1791-1795
Number of pages5
JournalJournal of Infectious Diseases
Volume182
Issue number6
DOIs
StatePublished - 2000

Fingerprint

caspofungin
Echinocandins
Cryptococcus neoformans
Glucans
Cell Wall
Immunoelectron Microscopy
Growth
Gold
Immune Sera
Fungi

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. / Feldmesser, M.; Kress, Y.; Mednick, A.; Casadevall, A.

In: Journal of Infectious Diseases, Vol. 182, No. 6, 2000, p. 1791-1795.

Research output: Contribution to journalArticle

Feldmesser, M. ; Kress, Y. ; Mednick, A. ; Casadevall, A. / The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. In: Journal of Infectious Diseases. 2000 ; Vol. 182, No. 6. pp. 1791-1795.
@article{7e95512d0cda44ac9762642a14705dd9,
title = "The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans",
abstract = "The echinocandin derivative caspofungin (MK-0991, L-743,872) inhibits 1,3-β-D-glucan synthesis and is active against several medically important fungi but is relatively ineffective against Cryptococcus neoformans. To investigate the mechanism of C. neoformans resistance, the prevalence of 1,3- and 1,6-β-D-glucan linkages was determined in cells grown with and without caspofungin, using affinity-purified antisera and gold particle immunoelectron microscopy. Cryptococcal strains ATCC 24067 (serotype D) and MY2061 (serotype A) were studied. Growth at 4 μg/mL of caspofungin reduced both glucan linkages in both strains. However, growth at 2 μg/mL resulted in reduced 1,6-β-D-glucan linkage only for MY2061. Inhibition of 1,6-β-D-glucan synthesis may be an additional mechanism of action for pneumocandins. The relatively low efficacy of caspofungin against C. neoformans may result from reduced activity against C. neoformans glucan synthase or from yet undiscovered mechanisms of action operative in other fungal pathogens but not in C. neoformans.",
author = "M. Feldmesser and Y. Kress and A. Mednick and A. Casadevall",
year = "2000",
doi = "10.1086/317614",
language = "English (US)",
volume = "182",
pages = "1791--1795",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans

AU - Feldmesser, M.

AU - Kress, Y.

AU - Mednick, A.

AU - Casadevall, A.

PY - 2000

Y1 - 2000

N2 - The echinocandin derivative caspofungin (MK-0991, L-743,872) inhibits 1,3-β-D-glucan synthesis and is active against several medically important fungi but is relatively ineffective against Cryptococcus neoformans. To investigate the mechanism of C. neoformans resistance, the prevalence of 1,3- and 1,6-β-D-glucan linkages was determined in cells grown with and without caspofungin, using affinity-purified antisera and gold particle immunoelectron microscopy. Cryptococcal strains ATCC 24067 (serotype D) and MY2061 (serotype A) were studied. Growth at 4 μg/mL of caspofungin reduced both glucan linkages in both strains. However, growth at 2 μg/mL resulted in reduced 1,6-β-D-glucan linkage only for MY2061. Inhibition of 1,6-β-D-glucan synthesis may be an additional mechanism of action for pneumocandins. The relatively low efficacy of caspofungin against C. neoformans may result from reduced activity against C. neoformans glucan synthase or from yet undiscovered mechanisms of action operative in other fungal pathogens but not in C. neoformans.

AB - The echinocandin derivative caspofungin (MK-0991, L-743,872) inhibits 1,3-β-D-glucan synthesis and is active against several medically important fungi but is relatively ineffective against Cryptococcus neoformans. To investigate the mechanism of C. neoformans resistance, the prevalence of 1,3- and 1,6-β-D-glucan linkages was determined in cells grown with and without caspofungin, using affinity-purified antisera and gold particle immunoelectron microscopy. Cryptococcal strains ATCC 24067 (serotype D) and MY2061 (serotype A) were studied. Growth at 4 μg/mL of caspofungin reduced both glucan linkages in both strains. However, growth at 2 μg/mL resulted in reduced 1,6-β-D-glucan linkage only for MY2061. Inhibition of 1,6-β-D-glucan synthesis may be an additional mechanism of action for pneumocandins. The relatively low efficacy of caspofungin against C. neoformans may result from reduced activity against C. neoformans glucan synthase or from yet undiscovered mechanisms of action operative in other fungal pathogens but not in C. neoformans.

UR - http://www.scopus.com/inward/record.url?scp=0033680483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033680483&partnerID=8YFLogxK

U2 - 10.1086/317614

DO - 10.1086/317614

M3 - Article

C2 - 11069257

AN - SCOPUS:0033680483

VL - 182

SP - 1791

EP - 1795

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -